Cargando…
Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: A strategy for prevention
BACKGROUND: Pneumocystis pneumonia (PCP) is an increasing problem amongst patients on immunosuppression with autoimmune inflammatory disorders (AID). The disease presents acutely and its diagnosis requires bronchoalveolar lavage in most cases. Despite treatment with intravenous antibiotics, PCP carr...
Autores principales: | Sowden, Evin, Carmichael, Andrew J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526257/ https://www.ncbi.nlm.nih.gov/pubmed/15488151 http://dx.doi.org/10.1186/1471-2334-4-42 |
Ejemplares similares
-
Pneumocystis jirovecii pneumonia following corticosteroid therapy
por: Garça, Magda, et al.
Publicado: (2023) -
Lessons from obesity prevention for the prevention of mental disorders: the primordial prevention approach
por: Hayward, Joshua, et al.
Publicado: (2014) -
Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
por: Parente, Luca
Publicado: (2017) -
Counterpoint: The value of benchmarking in observational studies of the longer term safety of antenatal corticosteroids
por: Hutcheon, Jennifer A., et al.
Publicado: (2022) -
Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity
por: Bonifacio, Ezio, et al.
Publicado: (2016)